Medicare spending cuts are affecting diabetes device companies like Insulet and Dexcom.
2 reports, 0 independent
Updated Jul 2
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Medicare spending cuts are affecting diabetes device companies like Insulet and Dexcom.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- CMS proposed payment reductions impacting diabetes care.Sub-event
- Medicare spending cuts impact diabetes device manufacturers Insulet and Dexcom.
Keep exploring
The entities involved
-
Insulet (United States)
insulin delivery device company
Nothing else this week.
-
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
Coverage
Newest first; wire copies grouped- Unknown outlet
- Unknown outlet